Literature DB >> 11247306

Prominin: a story of cholesterol, plasma membrane protrusions and human pathology.

D Corbeil1, K Röper, C A Fargeas, A Joester, W B Huttner.   

Abstract

Prominin is the first identified member of a novel family of polytopic membrane proteins conserved throughout the animal kingdom. It has an unusual membrane topology, containing five transmembrane domains and two large glycosylated extracellular loops. In mammals, prominin is expressed in various embryonic and adult epithelial cells, as well as in nonepithelial cells, such as hematopoietic stem cells. At the subcellular level, prominin is selectively localized in microvilli and other plasma membrane protrusions, irrespective of cell type. At the molecular level, prominin specifically interacts with membrane cholesterol and is a marker of a novel type of cholesterol-based lipid 'raft'. A frameshift mutation in the human prominin gene, which results in a truncated protein that is no longer transported to the cell surface, is associated with retinal degeneration. Given that prominin is concentrated in the plasma membrane evaginations at the base of the outer segment of rod photoreceptor cells, which are essential precursor structures in the biogenesis of photoreceptive disks, it is proposed that prominin has a role in the generation of plasma membrane protrusions, their lipid composition and organization and their membrane-to-membrane interactions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11247306     DOI: 10.1034/j.1600-0854.2001.020202.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  106 in total

1.  Proliferation of the ciliary epithelium with retinal neuronal and photoreceptor cell differentiation in human eyes with retinal detachment and proliferative vitreoretinopathy.

Authors:  Yvette Ducournau; Claude Boscher; Ron A Adelman; Colette Guillaubey; Didier Schmidt-Morand; Jean-François Mosnier; Didier Ducournau
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-20       Impact factor: 3.117

2.  Prominin-2 is a novel marker of distal tubules and collecting ducts of the human and murine kidney.

Authors:  József Jászai; Lilla M Farkas; Christine A Fargeas; Peggy Janich; Michael Haase; Wieland B Huttner; Denis Corbeil
Journal:  Histochem Cell Biol       Date:  2010-03-24       Impact factor: 4.304

Review 3.  Prostate epithelial stem cells.

Authors:  S Rizzo; G Attard; D L Hudson
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

4.  Amphiphile-induced tubular budding of the bilayer membrane.

Authors:  Veronika Kralj-Iglic; Henry Hägerstrand; Peter Veranic; Kristijan Jezernik; Blaz Babnik; Dorit R Gauger; Ales Iglic
Journal:  Eur Biophys J       Date:  2005-07-05       Impact factor: 1.733

5.  Functional role of microvesicles in gastrointestinal malignancies.

Authors:  Kelly McDaniel; Robert Correa; Tianhao Zhou; Christopher Johnson; Heather Francis; Shannon Glaser; Julie Venter; Gianfranco Alpini; Fanyin Meng
Journal:  Ann Transl Med       Date:  2013-04-01

6.  Differential expression of Prominin-1 (CD133) and Prominin-2 in major cephalic exocrine glands of adult mice.

Authors:  József Jászai; Peggy Janich; Lilla M Farkas; Christine A Fargeas; Wieland B Huttner; Denis Corbeil
Journal:  Histochem Cell Biol       Date:  2007-09-14       Impact factor: 4.304

Review 7.  CD133: to be or not to be, is this the real question?

Authors:  Elena Irollo; Giuseppe Pirozzi
Journal:  Am J Transl Res       Date:  2013-09-25       Impact factor: 4.060

8.  Prominin-2 expression increases protrusions, decreases caveolae and inhibits Cdc42 dependent fluid phase endocytosis.

Authors:  Raman Deep Singh; Andreas S Schroeder; Luana Scheffer; Eileen L Holicky; Christine L Wheatley; David L Marks; Richard E Pagano
Journal:  Biochem Biophys Res Commun       Date:  2013-04-10       Impact factor: 3.575

9.  High-level expression of stem cell marker CD133 in clear cell renal cell carcinoma with favorable prognosis.

Authors:  Kyungeun Kim; Hyojin Ihm; Jae Y Ro; Yong Mee Cho
Journal:  Oncol Lett       Date:  2011-08-02       Impact factor: 2.967

Review 10.  Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.

Authors:  Peyman Ranji; Tayyebali Salmani Kesejini; Sara Saeedikhoo; Ali Mohammad Alizadeh
Journal:  Tumour Biol       Date:  2016-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.